Trandermal delivery of opioids
US4626539A · kind A · utility
191Cited by
9References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 10, 1985 |
| Grant date | Dec 2, 1986 |
| Priority date | — |
| Expiry date | Jun 10, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/38
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Opioid-containing pharmaceutical compositions are provided which are useful in effecting transdermal delivery of a therapeutic dose of the opioid to the systemic circulation of a mammal. These pharmaceutical compositions consist essentially of the opioid, a penetration enhancer which is at least one of a saturated fatty alcohol or fatty acid of 8-15 carbon atoms or of an unsaturated fatty alcohol or fatty acid of 8-18 carbon atoms, and a suitable pharmaceutical carrier, preferably propylene glycol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.